Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma.
Jens BlobnerLaura DenglerSven BlobnerConstantin EberleJonathan WellerNico TeskePhilipp KarschniaKatharina RühlmannKathrin HeinrichFrank ZiemannPhilipp A GreifIrmela JeremiasRachel WuerstleinKorbinian HasselmannMario DorostkarPatrick N HarterStefanie QuachVeit StoeckleinNathalie L AlbertMaximilian NiyaziJoerg-Christian TonnNiklas ThonBenedikt Christoph WestphalenLouisa von BaumgartenPublished in: Neuro-oncology advances (2023)
In-depth molecular analysis of tumor tissue may guide targeted therapy also in brain tumor patients and considerable antitumor effects might be observed in selected cases. However, future studies to corroborate our results are needed.